Novelion Therapeutics Appoints Mark DiPaolo to Board of Directors
Aug 02, 2017 12:30 pm UTC| Business
VANCOUVER, British Columbia, Aug. 02, 2017 -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases, today...
Aug 02, 2017 12:30 pm UTC| Business
Three Month Revenue over $116,000 US, up 21%Company completes Phase 1A with microchip fabricatorLarge production SPS to be delivered August 2017 CERRITOS, Calif., Aug. 02, 2017 -- California Nanotechnologies Corp....
Sizmek Commences Tender Offer for All Outstanding Shares of Rocket Fuel
Aug 02, 2017 12:30 pm UTC| Business
NEW YORK and REDWOOD CITY, Calif., Aug. 02, 2017 -- Rocket Fuel Inc. (NASDAQ:FUEL) (“Rocket Fuel”) and Sizmek Inc. (“Sizmek”) today announced that Fuel Acquisition Co., a wholly owned subsidiary of Sizmek, has commenced...
Aqua Metals Successfully Hosts First Investor Day
Aug 02, 2017 12:30 pm UTC| Business
ALAMEDA, Calif., Aug. 02, 2017 -- Aqua Metals, Inc. (NASDAQ:AQMS), (“Aqua Metals” or the “Company”), which is commercializing a non-polluting electrochemical lead recycling technology called AquaRefining™, yesterday...
Versartis to Present at the Canaccord Genuity Growth Conference
Aug 02, 2017 12:30 pm UTC| Business
MENLO PARK, Calif., Aug. 02, 2017 -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan, a novel, long-acting form of recombinant human growth hormone (rhGH) for...
IES Holdings Announces Fiscal 2017 Third Quarter Earnings Release Schedule
Aug 02, 2017 12:30 pm UTC| Business
HOUSTON, Aug. 02, 2017 -- IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ:IESC) today announced that it will release fiscal 2017 third quarter results before the market opens on Friday, August 4, 2017. About...
FORM Holdings Corp to Present at the 37th Annual Canaccord Genuity Growth Conference in Boston
Aug 02, 2017 12:30 pm UTC| Business
NEW YORK, Aug. 02, 2017 -- FORM Holdings Corp. (“FORM”) (Nasdaq:FH), a diversified holding company, today announced that Andrew D. Perlman, Chief Executive Officer, will present at the 37th Annual Canaccord Genuity...